Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Quality Management System Oncology DFI Central surveillance system Clinical study CRF IB CDISC Bioequivalence Postmenopausal women Data Management Plan Subcontractor qualification IMPD Non interventional Pharmacodynamic studies Contraception Pragmatism Cough MDI NIS Training Good Clinical Practice Phase IV Absorption windows Adrenocortical Creativity EMA Product development Ophthalmology Allergy Experience Paediatricians Rhine Main area CRO Standard operating procedure Audit ADAM IVIVC Phase IIb trials First in human SAS Local tolerability In vitro in vivo correlation Asthma Cardiovascular surveillance Pharmacokintetics Dose linearity FIM Children Lung Pulse oximetry plethysmography COPD Safety Scientific expertise Transdermal therapeutic system Eye disease Sensitisation trials Post authorisation DDI Patients Metered dose inhaler MMM CDSIC DUS Authorities Axis Standardisation Phase I Unit Copyright Clinical pharmacology unit Quality Assurance Ophthalmologist Phase II HTA Drug Food Interaction SocraTec C&S SDV Investigators brochure Dry powder inhaler PASS Dry eye MCID US CFR 21 Part 11 Life cycle management Immunogenicity Recruitment rates GCP training Statistical Analysis Plan TTS Patient recruitment Anaesthesiologist Patch Biosimilars Biopharmaceutical Phase IIa trials Sequential designs Edema CDM Hypothalamic Referral system Quality Intensive assessment station Ophthalmological trials Spacious archive Macular Dermal irritation Legal representative Elpro Project Management Bioavailability HRT Ovulation inhibition Early phase Healthy subjects Legal Information Uveitis Auditing Degeneration Informed Consent Procedure Clinical development program Clinical Monitoring Monitoring SOP based Common cold Expert AGAH Pituitary Source Data Verification Feasibility OTC Network US FDA Protocol Absorption Slit lamp microscopy DPI PAES Ocular tolerability Statistical programming HPA axis Highly variable drugs ANVISA Xerostomia WinNonlin ICF Endpoint Efficacy Patch adhesion Charcoal Steady state FDA Scientific advice Drug Drug Interaction Oncologic network Clinical trials Competence GLP CDASH GCP Protocol development Statistical services Phase III Gynaecological trials IEC Biopharmaceutics Sore throat Thuringia Design development CRA Pharmacology Hormone replacement therapy Data management Glaucoma Oncological patients Sample size estimation Phase I Database Inspection Female adolescents Consultancy Inhalatives Pharmacokinetics Pilot study Centralised procedure Data Validation Plan Biometrics  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page